n-benzylglucamine dithiocarbamate has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, T; Hidaka, S; Kiyozumi, M; Kojima, S; Shimada, H; Tsuruoka, M | 1 |
| Hidaka, S; Inoue, T; Kiyozumi, M; Kojima, S; Tsuruoka, M | 1 |
2 other study(ies) available for n-benzylglucamine dithiocarbamate and Carcinoma 256, Walker
| Article | Year |
|---|---|
Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
Topics: Animals; Carcinoma 256, Walker; Chelating Agents; Cisplatin; Ditiocarb; Kidney; Male; Rats; Rats, Wistar; Sorbitol; Thiocarbamates | 1994 |
Protection against cis-diamminedichloroplatinum-induced nephrotoxicity in rats by N-benzyl-D-glucamine dithiocarbamate.
Topics: Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Carcinoma 256, Walker; Cisplatin; Female; Glycosuria; Kidney; Liver; Male; Platinum; Proteinuria; Random Allocation; Rats; Rats, Inbred Strains; Sorbitol; Thiocarbamates | 1991 |